Clinical and Economic Outcomes in Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass Surgery
- Conditions
- Morbid Obesity
- Interventions
- Procedure: Gastric Sleeve ResectionProcedure: Roux-en-Y Gastric Bypass
- Registration Number
- NCT01754194
- Lead Sponsor
- Medtronic - MITG
- Brief Summary
Study objectives:
1. generate local clinical, health-related quality-of-life and health economic data to evaluate the benefits of two types of minimally invasive weight-loss surgery
2. support multi-disciplinary bariatric sites in Germany by providing structured procedure guidelines and training, therefore facilitating procedural adoption, increasing safety and shortening the learning curve for weight-loss surgery.
- Detailed Description
The objectives of this study are the following: to generate local clinical, health-related quality-of-life and health economic data to evaluate the benefits of two types of minimally invasive weight-loss surgery; and to support multi-disciplinary bariatric sites in Germany by providing structured procedure guidelines and training, therefore facilitating procedural adoption, increasing safety and shortening the learning curve for weight-loss surgery.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 293
- All patients aged from 18 to 65 years of age, inclusive
- BMI > 40 or BMI > 35 with co-morbidities
- Eligible for weight-loss surgery
- Planned laparoscopic gastric sleeve resections or Roux-en-Y bypass surgery
- Insurance approval status: approved
- Written informed consent
- BMI > 55
- Planned two-stage procedures
- Prior bariatric procedures (including gastric banding)
- Serious mental or physical co-morbidities at the discretion of the Investigator
- Insurance approval status: rejected
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Procedure Type 1 Gastric Sleeve Resection Gastric Sleeve Resection Procedure Type 2 Roux-en-Y Gastric Bypass Roux-en-Y Gastric Bypass
- Primary Outcome Measures
Name Time Method Quality of Life (QOL) in First Postoperative Year According to EuroQol-5 Dimensions-5 Levels (EQ-5D-5L) 12 Months The EQ-5D-5L (minimum and maximum values are 0 and 1 respectively) consists of two sections,the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).The EQ-5D descriptive system comprises the following five dimensions: mobility,self-care,usual activities (e.g.,work, study..), pain/discomfort and anxiety/depression with five response levels for each dimension:no problems,slight problems, moderate problems,severe problems and extreme problems.The EQ-5D VAS is a 20 cm vertical scale where patients can mark from 0 (worst health imaginable) to 100 (best health imaginable).The global score at each timepoint is calculated as a composite of the five dimention score and of the VAS health score according to a specific algorithm.The Aurea Under the Curve (AUC) of QOL as assessed by EQ-5D-5L is reported to combine repeated measurements at flexible time intervals between 0 and 12 months post-procedure into a single numeric value.The higher the AUC value is,the better the patient is.
Quality of Life (QOL) in First Postoperative Year According to Bariatric Analysis and Reporting System (BAROS) With the Moorehead-Ardelt Quality of Life Questionnaire II (M-A QoLQ II) 12 months The BAROS consists of a scoring table that includes three main areas of analysis: weight loss, improvement of medical conditions and M-A QoLQ II. Points are added or subtracted according to changes in these domains. A maximum of three points is given to each domain to evaluate changes after medical or surgical intervention. Points are deducted for complications or reoperations. The M-A QoLQ II assesses six important QoL items (self-esteem, physical activity, social life, work conditions, sexual activity and eating behaviour) on a scale ranging from -0.50 to 0.50 with 0.10 increments to assess each item. The total number of points (range -7 to 9) defines five outcome groups from failure to excellent. The Aurea Under the Curve (AUC) of QOL as assessed by BAROS with M-A QoLQ II is reported to combine repeated measurements at flexible time intervals from 0 to 12 months post-procedure into a single numeric value. The higher the AUC value is, the better the patient is.
Quality of Life (QOL) in First Postoperative Year According to Impact of Weight on Quality of Life-Lite Questionnaire (IWQOL-Lite) 12 months The IWQoL-Lite consists of five domains: physical function (11 items), self-esteem (7 items), sexual life (4 items), public distress (5 items), and work (4 items). Each item has five response options: never true-1, rarely true-2, sometimes true-3, usually true-4, and always true-5. In computing raw and normalized scores, a pro-rated system is used for handling missing data. Normalized scores are used to obtain scores ranging from 0 (worst QoL) to 100 (best QoL). The Aurea Under the Curve (AUC) of QOL as assessed by IWQOL-Lite questionnaire is reported to combine repeated measurements at flexible time intervals from 0 to 12 months post-procedure into a single numeric value. The higher the AUC value is, the better the patient is.
- Secondary Outcome Measures
Name Time Method Excess Weight Loss (EWL) 12 Months EWL, calculated as a percentage, was used to compare weight loss between patients or types of bariatric procedures instead of actual weight loss.
The formula used was: EWL = 100 × actual weight loss (lbs)/(initial weight \[lbs\] - IBW \[lbs\]), where Actual weight loss was calculated as the difference between initial/pre-operative weight (lbs) and post-operative weight (lbs) and IBW was based on the 1983 Metropolitan Height (inches) and Weight (lbs). The Aurea Under the Curve (AUC) of EWL is reported to combine repeated measurements at flexible time intervals from 0 to 12 months post-procedure into a single numeric value. The higher the AUC value is, the more the patient lost weight.Health Resource Utilization - Durantion of Sugery 12 Months Health Resource Utilization - Recovery Time From Surgery 12 months Health Resource Utilization - Amount of Patients Requiring Transfer to ICU or Other Special Unit During Hospitalization 12 Months Surgical Complications 30 Days Incidence of procedural and post-procedural complications through 30 days post-op.
Trial Locations
- Locations (18)
Klinikum Itzehoe
🇩🇪Itzehoe, Germany
Diakoniekrankenhaus Mannheim
🇩🇪Mannheim, Germany
Bundeswehr Krankenhaus Berlin
🇩🇪Berlin, Germany
Ev. Krankenhaus Herne
🇩🇪Herne, Germany
Krankenhaus Luebbecke
🇩🇪Luebbecke, Germany
Schwarzwald Baar Klinikum Villingen
🇩🇪Villingen, Germany
Sana Klinikum Lübeck
🇩🇪Lübeck, Germany
Krankenhaus Hetzelstift Neustadt/Weinstraße
🇩🇪Neustadt, Germany
Thüringen-Kliniken "Georgius Agricola"
🇩🇪Saalfeld, Germany
Diakonie-Klinikum Schwäbisch Hall
🇩🇪Schwäbisch Hall, Germany
Franziskus Hospital Bielefeld
🇩🇪Bielefeld, Germany
BHV-Reinikenheide
🇩🇪Bremerhaven, Germany
Krankenhaus Bad Cannstatt
🇩🇪Bad Cannstatt, Germany
Universitätsklinik Hamburg Eppendorf
🇩🇪Hamburg, Germany
Amperklinikum Dachau
🇩🇪Dachau, Germany
Kreiskrankenhaus Emmendingen
🇩🇪Emmendingen, Germany
Marienkrankenhaus Kassel
🇩🇪Kassel, Germany
Krankenhaus Winsen
🇩🇪Winsen (Luhe), Germany